October 5, 2026StocksTechnology·Bullish·clinical trial
Australia's TGA grants Equillium ethics committee approval for Phase 1 trial of EQ504
Australia's Therapeutic Goods Administration granted Equillium human research ethics committee approval for a Phase 1 clinical trial of EQ504.
Detected & updated continuously · Source: Nebula
Story subjects
Equillium, Inc.EQ504